Skip to main content
Top

14-08-2024 | Alzheimer's Disease | Panel Discussion | Article | Lilly

Experts in Conversation

Representation in clinical trials and implementation of blood-based biomarkers

Suzanne Schindler and Charlotte Teunissen highlight discussions at CTAD 2024 on inclusive screening in clinical trials, use of blood-based biomarkers for diagnosis, and patient eligibility and dosing when using anti-amyloid therapies.

Related topics

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Advances in Alzheimer's

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Learn more